Cyclin D1 and human neoplasia

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Neoplasia is fundamentally linked to disruptions in normal cell cycle regulation.
• Cyclin D1, a protein encoded by the CCND1 gene, plays a critical role in cell cycle progression.
• Its aberrant expression is implicated in the development and progression of various cancers.

Purpose of the Study:

• To elucidate the role of Cyclin D1 in cell cycle regulation and its implications in neoplasia.
• To highlight the diagnostic and prognostic significance of Cyclin D1 alterations in specific cancers.
• To establish a foundation for developing targeted therapies against Cyclin D1 in malignancy.

Main Methods:

• Analysis of Cyclin D1 gene amplification and protein overexpression.
• Investigation of Cyclin D1's function in the G1 to S phase transition of the cell cycle.
• Correlation of Cyclin D1 alterations with diagnostic and prognostic outcomes in various cancers, particularly mantle cell lymphomas.

Main Results:

• Cyclin D1, in complex with cyclin-dependent kinases, phosphorylates the retinoblastoma gene product (pRB), facilitating cell cycle progression.
• CCND1 gene amplification or Cyclin D1 protein overexpression leads to uncontrolled cell proliferation and malignant transformation.
• Cyclin D1 alterations are valuable diagnostic markers in mantle cell lymphomas and possess prognostic significance across multiple cancer types.

Conclusions:

• Dysregulation of Cyclin D1 is a key mechanism in cancer development by disrupting cell cycle control.
• Assessing Cyclin D1 status provides critical diagnostic and prognostic information for cancer patients.
• Targeting Cyclin D1 represents a promising strategy for future cancer therapeutics.